Colcrys for Acute Gout Winston Salem NC

Colcrys has been approved by the U.S. Food and Drug Administration to treat acute gout and familial Mediterranean fever (FMF), two inflammatory disorders. The drug's active ingredient, colchicine, is derived from the dried seeds of the autumn crocus plant.

John S May, MD
(336) 716-4161
Medical Ctr Blvd
Winston Salem, NC
Business
John S WFUBMC
Specialties
Otolaryngology

Data Provided by:
Gary G Poehling, MD
(336) 716-8200
Medical Ctr Blvd
Winston Salem, NC
Business
WFUBMC Orthopaedics
Specialties
Orthopedics

Data Provided by:
Jerome E Jennings, MD
(336) 765-1571
1900 S Hawthorne Rd
Winston Salem, NC
Business
Jennings Clinic PA
Specialties
Orthopedics

Data Provided by:
Animal Hospital Of Clemmons
(336) 766-8950
2635 Neudorf Rd
Clemmons, NC

Data Provided by:
South Main Chiropractic and Wellness
(336) 313-9953
813 S Main St
Lexington, NC

Data Provided by:
Beverly N Jones MD
(336) 659-8817
3111 Maplewood Ave
Winston Salem, NC
Specialties
Psychiatry & Psychology

Data Provided by:
William Bryan Jennings, DO
(336) 765-1571
1900 S Hawthorne Rd
Winston Salem, NC
Business
Jennings Clinic PA
Specialties
Orthopedics

Data Provided by:
Piedmont Chiropractic Center
(336) 310-9936
851 Old Winston Rd #105
Kernersville, NC

Data Provided by:
Hillsdale Animal Hospital
(336) 998-8750
134 Medical Dr
Advance, NC

Data Provided by:
Stephen Lesher Leighton
(336) 723-9002
1430 Hsa Lane
Winston-Salem, NC
Specialty
Family Practice

Data Provided by:
Data Provided by:

Colcrys for Acute Gout

Provided By:

Colcrys has been approved by the U.S. Food and Drug Administration to treat acute gout and familial Mediterranean fever (FMF), two inflammatory disorders. The drug's active ingredient, colchicine, is derived from the dried seeds of the autumn crocus plant.

In a news release, the agency said colchicine has been used as a remedy to treat acute gout flares "for many years," despite that it hadn't been FDA approved. The agency said it was in the midst of a program to bring other similarly unapproved products under its regulatory authority.

A dosing study required for approval led the agency to recommend a lower dosing regimen for Colcrys that had been commonly prescribed, the news release said. This was designed to prevent gastrointestinal problems.

The FDA said it was alerting healthcare professionals of the lower dosing schedule and also warning that the drug had the potential for severe interactions with other medications.

FMF, common in Mediterranean nations but less so in the United States, has symptoms including fever, arthritis, and inflammation of the lining of the lungs and abdomen. Colcrys is now the first drug that's been FDA-approved to treat FMF, the agency said.

The drug is produced by Philadelphia-based Mutual Pharmaceutical Company Inc.

More information

The FDA has more about this medication's approval.

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com